VTYX
Ventyx Biosciences, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Ventyx Biosciences (VTYX) Stock: Buy, Sell, or Hold?
$14.00
+0.02 (+0.14%)
â˛
5d:
+0.29%
30d:
+0.36%
90d:
+40.0%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (62%)
Quality Score
51/100
Position
FAIR
Forward P/E & Valuation
-8.6x
Next 12M consensus est.
Wall Street Target
$13.29
-5.1% vs target
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$13.94 / $14.00
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: VTYX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When VTYX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: VTYX is currently trading at $14.00, which is considered fair based on recent price action.
Technical Outlook: Technically, VTYX is in a strong uptrend. The price is currently testing key support at $13.94. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VTYX is in a strong uptrend. The price is currently testing key support at $13.94. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
51/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
61.6%
Trading Range & Key Levels
Support Level
$13.94
Resistance Level
$14.00
Current Trend
Strong Uptrend
Technical data as of
Mar 3, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Trading above Wall St target ($13.29)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-8.59
Wall Street Target
$13.29
(-5.1%)
Share VTYX Analysis
Share this live VTYX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VTYX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Mar 3, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits user expressed disappointment over $VTYX's lack of earnings commentary during their last release and suggested it went against their obligation to shareholders. No new news articles were found.
Key Retail Themes:
Company's transparency
Shareholder obligations
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:43 AM ET
Data refreshes hourly during market hours. Next update: 3:43 AM
Data refreshes hourly during market hours. Next update: 3:43 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTYX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
28 analysts |
$91 | 56 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 33 SELL |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 34 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VTYX Research Pages
